ANZELLOTTI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 132
EU - Europa 131
AS - Asia 64
AF - Africa 1
Totale 328
Nazione #
US - Stati Uniti d'America 132
CN - Cina 33
UA - Ucraina 26
IE - Irlanda 22
GB - Regno Unito 19
SE - Svezia 18
SG - Singapore 14
TR - Turchia 14
DE - Germania 12
IT - Italia 12
FR - Francia 7
CZ - Repubblica Ceca 5
FI - Finlandia 5
RU - Federazione Russa 4
IN - India 2
BD - Bangladesh 1
BE - Belgio 1
EG - Egitto 1
Totale 328
Città #
Jacksonville 30
Chandler 23
Dublin 22
Southend 18
Singapore 11
Dearborn 10
Nanjing 10
Princeton 10
Beijing 9
Altamura 6
Ashburn 6
Kocaeli 6
Cambridge 5
Chieti 5
Izmir 5
Brno 4
Hebei 4
Wilmington 4
Munich 3
Düsseldorf 2
Nanchang 2
New York 2
Santa Clara 2
Tianjin 2
Augusta 1
Brussels 1
Cairo 1
Changsha 1
Denver 1
Edinburgh 1
Grevenbroich 1
Jiaxing 1
Kunming 1
Moscow 1
Norwalk 1
Olomouc 1
San Mateo 1
Seattle 1
Shanghai 1
Shaoxing 1
Spoltore 1
Washington 1
Totale 219
Nome #
Low-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjects: recommendations to minimize the functional consequences 86
NCX 4040, a Nitric Oxide-Donating Aspirin, Exerts Anti-Inflammatory Effects through Inhibition of I{kappa}B-{alpha} Degradation in Human Monocytes. 80
Novel analgesic/anti-inflammatory agents: diarylpyrrole acetic esters endowed with nitric oxide releasing properties. 68
Novel analgesic/anti-inflammatory agents: 1,5-diarylpyrrole nitrooxyalkyl ethers and related compounds as cyclooxygenase-2 inhibiting nitric oxide donors. 66
Enlarging the NSAIDs family: ether, ester and acid derivatives of the 1,5-diarylpyrrole scaffold as novel anti-inflammatory and analgesic agents. 48
Totale 348
Categoria #
all - tutte 1.574
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.574


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202025 0 0 0 0 0 0 6 5 1 2 11 0
2020/202134 5 0 5 0 1 5 1 0 3 11 3 0
2021/202224 0 0 0 8 0 0 2 1 1 1 4 7
2022/202371 7 16 3 5 3 13 6 3 10 0 2 3
2023/202438 1 5 1 0 4 10 7 2 0 0 1 7
2024/202530 5 8 6 1 3 7 0 0 0 0 0 0
Totale 348